跳至主要内容
临床试验/NCT03250091
NCT03250091招募中不适用

Surveillance Strategies of Patients With Precancerous Conditions and Lesions in the Stomach

University of Latvia1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2017年6月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,000
试验地点
1
主要终点
Risk stratification

研究概览

简要总结

The project will aim to identify and determine subgroups of patients with different risks of progression to gastric cancer and to assess appropriate follow-up intervals. Implementing risk stratification only high risk individuals will be offered and performed endoscopic surveillance.

详细描述

Gastric cancer is still an important healthcare problem with significant mortality rates. Latvia is a high incidence country of gastric cancer. Unfortunately most of the gastric cancer cases in Latvia are diagnosed at late stages when the treatment is substantially less effective.

Ideally, gastric cancer could be prevented by detecting gastric precancerous conditions/lesions and identifying those individuals at high-risk of progressing to cancer to the follow-up.

Population based endoscopic screening for gastric cancer is not recommended for the early detection of gastric cancer generally deemed not to be cost-effective.

However, in the absence of screening, patients present with advanced disease, and prognosis is poor.

Targeted endoscopic surveillance strategies for gastric cancer should be introduced following the principles of the recent European guidelines: Management of precancerous conditions and lesions in the stomach (MAPS) (Dinis-Ribeiro, Areia et al. 2012).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing upper endoscopy Motivation to participate in the study Signed consent

排除标准

  • Known gastric cancer Unwillingness or inability to co-operate

结局指标

主要结局

Risk stratification

时间窗: At baseline

The patients with material of standardized biopsies according to the standard criteria (updated Sydney system) will be classified in different risk groups for progressing to gastric cancer. The measurements for the risk stratification will be used following the updated Sydney grading and classification system e.g. degree and extent of atrophy, intestinal metaplasia and dysplasia in the stomach mucosa

次要结局

  • Scheduled follow-up procedures (gastroscopies) for high risk group patients(At baseline and then 1 and 3 years after the intervention depending on hystopathological report through study completion)
  • Gastric, faecal microbiome in cancer patients and patients with precancerous lesions(At baseline and then 1 and 3 years after the intervention depending on hystopathological report through study completion)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验